Surge In Eye-related Conditions Fueling Growth Of The Market Due To Rising Risk Of Vision Loss Is Supporting Development Across The Onchocerciasis Treatment Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Onchocerciasis Treatment Market During 2026–2030?

The onchocerciasis treatment market size has observed substantial growth in recent years. It is projected to increase from $1.11 billion in 2025 to $1.19 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.8%. This historic growth can be attributed to several factors, including the limited availability of ivermectin and doxycycline in endemic regions, a reliance on hospital-based distribution channels, low awareness concerning onchocerciasis management, inadequate preventive chemotherapy programs, and a dependency on oral formulations only.

The onchocerciasis treatment market is projected to experience substantial expansion over the coming years. It is anticipated to reach a valuation of $1.59 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. This anticipated growth during the forecast period can be attributed to several factors, including the introduction of moxidectin and long-acting formulations, the broadening of online and retail pharmacy distribution channels, the advancement of combination therapies, enhanced funding from government and non-governmental organizations (NGOs) for eradication initiatives, and the implementation of community-based preventive approaches. Key trends expected during this period involve the scaling up of mass drug administration (MDA) programs, the creation of pediatric and fixed-dose formulations, a greater emphasis on anti-wolbachia therapies, the incorporation of both oral and injectable treatment regimens, and an increase in community-based and government-backed treatment campaigns.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24634&type=smp

Which Major Factors Are Contributing To The Development Of The Onchocerciasis Treatment Market?

The rising number of individuals facing eye-related issues is projected to boost the growth of the onchocerciasis treatment market in the future. Eye-associated issues cover various conditions impacting vision and ocular health, including infections, injuries, and chronic ailments such as glaucoma or cataracts. The increase in patients with eye-related problems is mainly due to heightened screen time and extended exposure to digital devices. Onchocerciasis treatment works by eradicating the parasitic infection that causes inflammation and damage to ocular tissues, thereby assisting in the prevention and management of vision loss and blindness. For example, according to the Centers for Disease Control and Prevention (CDC) in **May 2024**, around **20.5 million Americans** over the age of 40 had cataracts in at least one eye, accounting for **17.2%** of that demographic. It is foreseen that nearly **30 million** people will develop cataracts by **2028**. Consequently, the increasing prevalence of eye conditions is fueling expansion in the onchocerciasis treatment market. The growing demand for surgical interventions is expected to drive the onchocerciasis treatment market forward. Surgical procedures refer to medical operations designed to remove or repair tissues damaged by disease, frequently utilized when drug therapies are ineffective or when complications pose a threat to long-term health. This increase is driven by the progression of onchocerciasis in some patients to advanced stages, where surgery becomes essential to prevent permanent damage like vision loss or disfigurement. As a result, healthcare providers are expanding surgical capabilities and investing in advanced techniques, thus boosting the overall market for onchocerciasis treatment. For instance, in **June 2024**, the International Society of Aesthetic Plastic Surgery (ISAPS) reported that in **2023**, nearly **35 million** aesthetic procedures were conducted globally, representing a **3.4%** increase from **2022**. The report also indicated that surgical procedures climbed by **5.5%**, with more than **15.8 million** procedures performed by plastic surgeons. Therefore, the rising requirement for surgical procedures is propelling growth in the onchocerciasis treatment market.

How Is The Onchocerciasis Treatment Market Structured Across Different Market Segments?

The onchocerciasis treatment market covered in this report is segmented –

1) By Drug Type: Ivermectin, Doxycycline, Albendazole, Moxidectin

2) By Treatment Strategy: Mass Drug Administration (MDA), Targeted Treatment

3) By Mode Of Administration: Oral, Injectables, Topical

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals And Clinics, Home Care Settings, Government And Non-Governmental Programs

Subsegments:

1) By Ivermectin: Oral Tablets, Community-Based Mass Drug Administration (MDA) Kits, Fixed-Dose Combination Therapies, Pediatric Formulations

2) By Doxycycline: Oral Capsules, Extended-Release Tablets, Combination With Anti-Wolbachia Therapy, Hospital-Based Prescription Treatments

3) By Albendazole: Single-Dose Oral Tablets, Combination Therapy With Ivermectin, Government-Supplied Preventive Chemotherapy Packages, Over-The-Counter (OTC) Formulations In Endemic Areas

4) By Moxidectin: Oral Tablets, Long-Acting Formulations, Adult-Only Dosing Regimens, Clinical Trial-Based Access Programs

What Trends Are Influencing The Onchocerciasis Treatment Market?

Leading companies active in the onchocerciasis treatment market are prioritizing the development of novel antiparasitic medicines to improve the efficacy and reduce the duration of treatment. Antiparasitic medications are pharmaceutical agents designed to eliminate or inhibit parasites such as worms and protozoa, which are known to cause infections in humans. For instance, in December 2024, Medicines Development for Global Health (MDGH), an Australia-based non-profit biopharmaceutical company, obtained approval from the Ghana Food and Drugs Authority (FDA) for Moxidectin 2 mg oral tablets intended for the treatment of river blindness in individuals aged 4 years and older. This authorization allows Ghana to implement community-based mass drug administration programs using moxidectin, which provides enhanced efficacy and more prolonged effects compared to ivermectin. With this recent approval, MDGH aims to expand access to an effective new therapy for onchocerciasis, enabling large-scale community initiatives in endemic regions.

Who Are The Major Companies Operating In The Onchocerciasis Treatment Market?

Major companies operating in the onchocerciasis treatment market are Merck & Co. Inc., Teva Pharmaceutical Industries Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Dr. Reddy’s Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos – Fundação Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Rakshit Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, Cerata Pharmaceuticals Inc.

Access The Complete Onchocerciasis Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/onchocerciasis-treatment-global-market-report

Which Region Stands As The Largest Contributor To The Onchocerciasis Treatment Market?

North America was the largest region in the onchocerciasis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onchocerciasis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Onchocerciasis Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24634&type=smp

Browse Through More Reports Similar to the Global Onchocerciasis Treatment Market 2026, By The Business Research Company

Oncology Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-global-market-report

Oncology Companion Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncology-companion-diagnostics-global-market-report

Oncologists Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795